Glucose intolerance induced by glucocorticoid excess is further impaired by co-administration with β-hydroxy-β-methylbutyrate in rats
Glucose intolerance induced by glucocorticoid excess is further impaired by co-administration with β-hydroxy-β-methylbutyrate in rats
Glucocorticoid (GC) excess alters glucose homeostasis and promotes modifications in murinometric and anthropometric parameters in rodents and humans, respectively. β-hydroxy-β-methylbutyrate (HMB), a leucine metabolite, has been proposed as a nutritional strategy for preventing muscle wasting, but few data regarding its effects on glucose homeostasis are available. Here, we analyzed whether the effects of GC excess on glucose homeostasis may be attenuated or exacerbated by the concomitant ingestion of HMB. Adult Wistar rats (90-days-old) were assigned to four groups: (1) vehicle treated (Ctl), (2) dexamethasone (DEX) treated (Dex), (3) HMB treated (Hmb), and (4) DEX plus HMB treated (DexHmb). Dex groups received DEX (1 mg·kg body weight BW-1, intraperitoneal) for 5 consecutive days. HMB groups ingested HMB (320 mg·kg BW-1, oral gavage) for the same 5 days. HMB ingestion did not attenuate the effects of DEX on food intake and body weight loss, changes in masses of several organs, insulin resistance, and glucose intolerance (p > 0.05). In fact, in DexHmb rats, there was increased fasting glycemia and exacerbated glucose intolerance with the main effect attributed to DEX treatment (p < 0.05). HMB exerted no attenuating effect on plasma triacylglycerol levels from DexHmb rats, but it seems to attenuate the lipolysis induced by β-adrenergic stimulation (20 µmol·L-1 isoproterenol) in fragments of retroperitoneal adipose tissue from DexHmb rats. Therefore, HMB does not attenuate the diabetogenic characteristics of GC excess. In fact, the data suggest that HMB may exacerbate GC-induced glucose intolerance.
1137-1146
Nunes, E.
ca193ed2-d093-49a3-9deb-c67d3c2af29a
Gonçalves-Neto, L.
845996c4-4dea-4a18-9789-cd22c4e231a2
Ferreira, F.
316028c4-9ae3-41c8-b09a-f9a70020aae7
Dos Santos, C.
b89cca06-c4ca-4480-8985-db38c6a83b4d
Fernandes, L.
720f3244-8af4-4330-9e0d-a2aa42fb4743
Boschero, A.
1362ff4d-6d38-4765-9178-42d61344a68e
Calder, Philip C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
17 June 2013
Nunes, E.
ca193ed2-d093-49a3-9deb-c67d3c2af29a
Gonçalves-Neto, L.
845996c4-4dea-4a18-9789-cd22c4e231a2
Ferreira, F.
316028c4-9ae3-41c8-b09a-f9a70020aae7
Dos Santos, C.
b89cca06-c4ca-4480-8985-db38c6a83b4d
Fernandes, L.
720f3244-8af4-4330-9e0d-a2aa42fb4743
Boschero, A.
1362ff4d-6d38-4765-9178-42d61344a68e
Calder, Philip C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Nunes, E., Gonçalves-Neto, L., Ferreira, F., Dos Santos, C., Fernandes, L., Boschero, A. and Calder, Philip C.
(2013)
Glucose intolerance induced by glucocorticoid excess is further impaired by co-administration with β-hydroxy-β-methylbutyrate in rats.
Applied Physiology, Nutrition and Metabolism, 38 (11), .
(doi:10.1139/apnm-2012-0456).
(PMID:24053521)
Abstract
Glucocorticoid (GC) excess alters glucose homeostasis and promotes modifications in murinometric and anthropometric parameters in rodents and humans, respectively. β-hydroxy-β-methylbutyrate (HMB), a leucine metabolite, has been proposed as a nutritional strategy for preventing muscle wasting, but few data regarding its effects on glucose homeostasis are available. Here, we analyzed whether the effects of GC excess on glucose homeostasis may be attenuated or exacerbated by the concomitant ingestion of HMB. Adult Wistar rats (90-days-old) were assigned to four groups: (1) vehicle treated (Ctl), (2) dexamethasone (DEX) treated (Dex), (3) HMB treated (Hmb), and (4) DEX plus HMB treated (DexHmb). Dex groups received DEX (1 mg·kg body weight BW-1, intraperitoneal) for 5 consecutive days. HMB groups ingested HMB (320 mg·kg BW-1, oral gavage) for the same 5 days. HMB ingestion did not attenuate the effects of DEX on food intake and body weight loss, changes in masses of several organs, insulin resistance, and glucose intolerance (p > 0.05). In fact, in DexHmb rats, there was increased fasting glycemia and exacerbated glucose intolerance with the main effect attributed to DEX treatment (p < 0.05). HMB exerted no attenuating effect on plasma triacylglycerol levels from DexHmb rats, but it seems to attenuate the lipolysis induced by β-adrenergic stimulation (20 µmol·L-1 isoproterenol) in fragments of retroperitoneal adipose tissue from DexHmb rats. Therefore, HMB does not attenuate the diabetogenic characteristics of GC excess. In fact, the data suggest that HMB may exacerbate GC-induced glucose intolerance.
This record has no associated files available for download.
More information
Published date: 17 June 2013
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 359028
URI: http://eprints.soton.ac.uk/id/eprint/359028
ISSN: 1715-5312
PURE UUID: 260c1cf0-cbb6-4ec0-b4d1-0405963887bf
Catalogue record
Date deposited: 18 Oct 2013 13:47
Last modified: 15 Mar 2024 02:50
Export record
Altmetrics
Contributors
Author:
E. Nunes
Author:
L. Gonçalves-Neto
Author:
F. Ferreira
Author:
C. Dos Santos
Author:
L. Fernandes
Author:
A. Boschero
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics